Product Description: Elosulfase alfa (BMN 110) is a recombinant form of human N-acetylgalactosamine-6-sulfatase (GALNS). Elosulfase alfa is used as an enzyme replacement therapy for mucopolysaccharidosis IVA (MPS IVA), also known as Morquio A syndrome[1].
Formula: N/A
References: [1]Sanford M, et al. Elosulfase alfa: first global approval. Drugs. 2014 Apr;74(6):713-8.